Skip to content

Elona Health GmbH

Request correction

Corporate brand

Unclaimed

German digital-health company building prescription-based psychotherapy apps that support patients before and during therapy.

Last updated September 28, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Elona Health GmbH is a German digital-health company headquartered in Düsseldorf that develops prescription-based digital therapeutics for mental health. Its stated mission is to "shape the psychotherapy of tomorrow" by strengthening the therapeutic alliance between patients and therapists and by relieving therapists of administrative burden so they can focus on treatment. The company positions itself as a partner to the outpatient psychotherapy system rather than a replacement for it, describing its ambition as a "revolution from within" of ambulatory psychological care. The company's product family is built around apps that can be prescribed in Germany ("Apps auf Rezept"), meaning they are intended to be reimbursable digital health applications (DiGA) within the German statutory health-insurance framework. Its offerings are organized around two moments in the patient journey: before psychotherapy and during psychotherapy. elona explore is described as a first-aid app for mental health, designed to bridge waiting times for psychotherapy or to directly alleviate psychological complaints, and is offered free of charge. elona therapy is the core therapeutic application, and a group-therapy variant, elona therapy for group therapy, extends the same approach to group settings. Elona Health frames its work around documented gaps in mental-healthcare provision. On its website it cites that up to 65% of patients with depression or anxiety disorders relapse after treatment, that up to 79% of people with depression or anxiety disorders receive no treatment at all, and that psychotherapy takes almost two years on average. It also highlights patient-side problems such as difficulty finding the right help, waiting more than five months on average for a first appointment, and a lack of support between weekly 50-minute sessions, as well as therapist-side problems such as the 38% of time spent on non-patient work and dissatisfaction with the adherence of about half of their patients. The company emphasizes evidence-based development, medical quality and regulatory conformity, and user-centered design across its product process. It maintains a scientific advisory board that brings together perspectives from clinical psychology to support the quality, safety and innovative strength of its products. Its leadership team combines clinical, therapeutic, strategic and technical roles, including co-founder Alexander Braden, Managing Director and Head of Strategy Magnus Schückes, Chief Therapy Officer Johanna von Lobenstein, Chief Medical Officer Dr. Peter Neudeck and Chief Technology Officer Leon Hillebrandt. Elona Health operates primarily in the German market, where prescription digital therapeutics are integrated into the healthcare system. It serves two main audiences: patients, who use the apps on prescription, and healthcare professionals, who use them alongside conventional psychotherapy. The company is privately held and, as of the available evidence, does not disclose a parent company or stock listing.

History

Elona Health GmbH is a privately held German digital-health company based in Düsseldorf. It was founded to develop prescription-based digital therapeutics for mental health, with the goal of improving how psychotherapy is delivered in the German healthcare system. The company describes its mission as "shaping the psychotherapy of tomorrow" and frames its work as a "revolution from within" of outpatient psychotherapy — not replacing therapists, but relieving them of paperwork and bureaucracy so they can concentrate on treating patients. From its outset, Elona Health has organized its products around the patient journey in psychotherapy. Its first-step offering, elona explore, is a free mental-health first-aid app intended to bridge the waiting period before psychotherapy or to directly alleviate psychological complaints. Its core product, elona therapy, is a prescription-based application used before and during psychotherapy. The company later extended the approach to group settings with elona therapy for group therapy, marketed under the message "same DiGA, even more support." The reference to DiGA indicates that the products are designed as reimbursable digital health applications within Germany's statutory health-insurance system. The company's development philosophy emphasizes evidence-based work, medical quality and regulatory conformity, and user-centered design. It states that evidence-based practice runs through its entire product process and that innovative therapy methods support the effectiveness of its applications. To reinforce clinical credibility, Elona Health maintains a scientific advisory board that combines perspectives from clinical psychology to support the quality, safety and innovative strength of its products. Elona Health's leadership team reflects this blend of clinical, therapeutic, strategic and technical expertise. Co-founder Alexander Braden is listed alongside Managing Director and Head of Strategy Magnus Schückes, Chief Therapy Officer Johanna von Lobenstein, Chief Medical Officer Dr. Peter Neudeck and Chief Technology Officer Leon Hillebrandt. The company serves two primary audiences — patients who use the apps on prescription and healthcare professionals who use them alongside conventional psychotherapy — and operates primarily in the German market. As of the available evidence, it remains privately held and does not disclose a parent company or public listing.

  • Elona Health is founded as a digital-health company in Düsseldorf, Germany, focused on prescription-based psychotherapy apps.

  • elona explore is offered as a free mental-health first-aid app to bridge waiting times before psychotherapy.

  • elona therapy is developed as a prescription-based application for use before and during psychotherapy.

  • elona therapy for group therapy is introduced, extending the DiGA approach to group settings.

Products and positioning

Prescription-based digital therapeutics that strengthen the therapeutic alliance and relieve therapists, positioned as a partner to outpatient psychotherapy in Germany.

  • elona explore

    A free mental-health first-aid app, the first step toward better mental health, used to bridge waiting times for psychotherapy or to directly alleviate psychological complaints.

  • elona therapy

    A prescription-based digital therapeutic app that supports patients before and during psychotherapy.

  • elona therapy for group therapy

    A group-therapy variant of elona therapy, marketed as the same DiGA with even more support.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/elona-health-gmbh-germany · Editorial policy · How profiles are compiled